Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Puma Biotechnology
PBYI
$403M
| $2.57M | ﹤0.01% |
279,675
+11,719
| +4% | +$119K |
|
|
RAPT
2627
DELISTED
RAPT Therapeutics
RAPT
| $2.57M | ﹤0.01% |
10,095
+1,845
| +22% | +$345K |
|
2628
Select Water Solutions
WTTR
$2.3B
| $2.54M | ﹤0.01% |
421,277
-3,767
| -0.9% | -$21.7K |
|
2629
Vital Farms
VITL
$545M
| $2.53M | ﹤0.01% |
126,623
+5,028
| +4% | +$111K |
|
2630
Seneca Foods Class A
SENEA
$1.12B
| $2.53M | ﹤0.01% |
49,453
-8,014
| -14% | -$387K |
|
|
DSKE
2631
DELISTED
Daseke, Inc. Common Stock
DSKE
| $2.51M | ﹤0.01% |
387,296
+7,004
| +2% | +$50.8K |
|
2632
LoveSac
LOVE
$234M
| $2.5M | ﹤0.01% |
31,394
+6,388
| +26% | +$476K |
|
2633
OptimizeRx
OPRX
$114M
| $2.5M | ﹤0.01% |
40,347
+730
| +2% | +$37.1K |
|
|
ITOS
2634
DELISTED
iTeos Therapeutics
ITOS
| $2.49M | ﹤0.01% |
97,086
+3,374
| +4% | +$80.4K |
|
|
INBX
2635
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $2.49M | ﹤0.01% |
90,448
+38,950
| +76% | +$811K |
|
|
PLYM
2636
DELISTED
Plymouth Industrial REIT
PLYM
| $2.48M | ﹤0.01% |
124,084
+9,066
| +8% | +$171K |
|
2637
FRP Holdings
FRPH
$428M
| $2.48M | ﹤0.01% |
88,940
+2,684
| +3% | +$74.3K |
|
|
GAN
2638
DELISTED
GAN Ltd
GAN
| $2.48M | ﹤0.01% |
150,580
+82,408
| +121% | +$1.45M |
|
|
MPX
2639
DELISTED
Marine Products Corp
MPX
| $2.48M | ﹤0.01% |
160,324
+2,513
| +2% | +$41.7K |
|
|
ROCC
2640
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $2.47M | ﹤0.01% |
104,639
+1,622
| +2% | +$29.6K |
|
2641
Treace Medical Concepts
TMCI
$278M
| $2.46M | ﹤0.01% |
+78,757
| New | +$2.51M |
|
|
IDEX
2642
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $2.46M | ﹤0.01% |
+6,929
| New | +$2.47M |
|
|
ATNX
2643
DELISTED
Athenex, Inc. Common Stock
ATNX
| $2.46M | ﹤0.01% |
26,595
+3,381
| +15% | +$307K |
|
|
BCOV
2644
DELISTED
Brightcove, Inc.
BCOV
| $2.46M | ﹤0.01% |
171,206
+71,669
| +72% | +$1.15M |
|
|
DMTK
2645
DELISTED
DermTech, Inc. Common Stock
DMTK
| $2.46M | ﹤0.01% |
59,073
+28,443
| +93% | +$1.17M |
|
2646
Forestar Group
FOR
$1.43B
| $2.46M | ﹤0.01% |
117,375
+3,533
| +3% | +$82.6K |
|
2647
Regional Management Corp
RM
$302M
| $2.45M | ﹤0.01% |
52,685
-6,990
| -12% | -$303K |
|
2648
Mission Produce
AVO
$1.11B
| $2.43M | ﹤0.01% |
117,428
+62,948
| +116% | +$1.29M |
|
2649
ANI Pharmaceuticals
ANIP
$1.8B
| $2.43M | ﹤0.01% |
69,293
+9,951
| +17% | +$339K |
|
|
VEI
2650
DELISTED
Vine Energy Inc.
VEI
| $2.42M | ﹤0.01% |
+155,123
| New | +$2.13M |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.